116
Views
2
CrossRef citations to date
0
Altmetric
Review

The use of ultra-widefield imaging for the management of diabetic retinopathy

&
Pages 485-494 | Received 08 Aug 2017, Accepted 23 Oct 2017, Published online: 02 Nov 2017

References

  • Talks SJ, Manjunath V, Steel DHW, et al. New vessels detected on wide-field imaging compared to two-field and seven-field imaging: implications for diabetic retinopathy screening image analysis. Br J Ophthalmol. 2015;99:1606–1609.
  • Rasmussen ML, Broe R, Frydkjaer-Olsen U, et al. Comparison between Early Treatment Diabetic Retinopathy Study 7-field retinal photos and non-mydriatic, mydriatic and mydriatic steered widefield scanning laser ophthalmoscopy for assessment of diabetic retinopathy. J Diabetes Complications. 2015;29:99–104.
  • Sagong M, Van Hemert J, Lc ODK, et al. Assessment of accuracy and precision of quantification of ultra-widefield images. Ophthalmology. 2015;122:864–866.
  • Shiibashi M, Yoshimoto M, Shigeeda T, et al. Experience using the heidelberg retina angiograph 2 with a wide-field contact lens system in diabetic retinopathy cases. Open Ophthalmol J. 2013;7:54–57.
  • Staurenghi G, Viola F, Mainster MA, et al. Scanning laser ophthalmoscopy and angiography with a wide-field contact lens system. Arch Ophthalmol. 2005;123:244–252.
  • Witmer MT, Parlitsis G, Patel S, et al. Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis® noncontact ultra-widefield module versus the Optos® Optomap®. Clin Ophthalmol. 2013;7:389–394.
  • Witmer MT, Wide-Field KS. Imaging of the retina. Surv Ophthalmol. 2013;58:143–154.
  • Shoughy SS, Arevalo JF, Kozak I. Update on wide- and ultra-widefield retinal imaging. Indian J Ophthalmol. 2015;63:575–581.
  • Maamari RN, Keenan JD, Fletcher DA, et al. A mobile phone-based retinal camera for portable wide field imaging. Br J Ophthalmol. 2014;98:438–441.
  • Choudhry N, Golding J, Manry M, et al. Ultra-widefield steering-based SD-OCT imaging of the retinal periphery. Ophthalmology. 2016;2:1368–1374.
  • Taylor R, Lovelock L, Tunbridge WM, et al. Comparison of non-mydriatic retinal photography with ophthalmoscopy in 2159 patients: mobile retinal camera study. BMJ. 1990;301:1243–1247.
  • Arun CS, Ngugi N, Lovelock L, et al. Effectiveness of screening in preventing blindness due to diabetic retinopathy. Diabet Med. 2003;20:186–190.
  • Arun CS, Al-Bermani A, Stannard K, et al. Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age population. Diabet Med. 2009;26:488–492.
  • Talks SJ, Gupta R, Buckley S. The incidence of diabetic retinopathy requiring treatment is also low in the under 90 age group. Eye. 2016;30:1146–1146.
  • Virgili G, Menchini F, Dimastrogiovanni AF, et al. Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Investig Ophthalmol Vis Sci. 2007;48:4963–4973.
  • Silva PS, Cavallerano JD, Sun JK, et al. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-Field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. Am J Ophthalmol. 2012;154:549–559.e2.
  • Kernt M, Hadi I, Pinter F, et al. Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography. Diabetes Care. 2012;35:2459–2463.
  • Silva PS, Horton MB, Clary D, et al. Identification of diabetic retinopathy and ungradable image rate with ultrawide field imaging in a national teleophthalmology program. Ophthalmology. 2016;123:1360–1367.
  • Horton MB, Silva PS, Cavallerano JD, et al. Clinical components of telemedicine programs for diabetic retinopathy. Curr Diab Rep. 2016;16:129.
  • Silva PS, Cavallerano JD, Tolson AM, et al. Real-time ultrawide field image evaluation of retinopathy in a diabetes telemedicine program. Diabetes Care. 2015;38:1643–1649.
  • Horton MB, Silva PS, Cavallerano JD, et al. Operational components of telemedicine programs for diabetic retinopathy. Curr Diab Rep. 2016;16:128.
  • Manjunath V, Papastavrou V, Steel DHW, et al. Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening. Eye (Lond). 2015;29:416–423.
  • Silva PS, Cavallerano JD, Haddad NMN, et al. Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years. Ophthalmology. 2015;122:949–956.
  • Silva PS, El-Rami H, Barham R, et al. Hemorrhage and/or microaneurysm severity and count in ultrawide field images and early treatment diabetic retinopathy study photography. Ophthalmology. 2017;124:970–976.
  • Silva PS, Cavallerano JD, Sun JK, et al. Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity. Ophthalmology. 2013;120:2587–2595.
  • Bae K, Lee JY, Kim TH, et al. Anterior diabetic retinopathy studied by ultra-widefield angiography. Korean J Ophthalmol. 2016;30:344–351.
  • National Eye Institute (NEI). Diabetic retinopathy clinical research network (DRCRnet) public web site [internet]. [cited 2017 Aug 2]. Available from: http://drcrnet.jaeb.org/ViewPage.aspx?PageName=General_Info.
  • Silva PS, Dela Cruz AJ, Ledesma MG, et al. Diabetic retinopathy severity and peripheral lesions are associated with nonperfusion on ultrawide field angiography. Ophthalmology. 2015;122:2465–2472.
  • Wessel MM, Aaker GD, Parlitsis G, et al. Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina. 2012;32:785–791.
  • Sim DA, Keane PA, Rajendram R, et al. Patterns of peripheral retinal and central macula ischemia in diabetic retinopathy as evaluated by ultra-widefield fluorescein angiography. Am J Ophthalmol. 2014;158:144–153.e1.
  • Wessel MM, Nair N, Aaker GD, et al. Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema. Br J Ophthalmol. 2012;96:694–698.
  • Patel RD, L V M, Teitelbaum B, et al. Characterization of ischemic index using ultra-widefield fluorescein angiography in patients with focal and diffuse recalcitrant diabetic macular edema. Am J Ophthalmol. 2013;155:1038–1044.e2.
  • Xue K, Yang E, Chong NV. Classification of diabetic macular oedema using ultra-widefield angiography and implications for response to anti-VEGF therapy. Br J Ophthalmol. 2017;101:559–563.
  • Fan W, Wang K, Ghasemi Falavarjani K, et al. Distribution of nonperfusion area on ultra-widefield fluorescein angiography in eyes with diabetic macular edema: DAVE study. Am J Ophthalmol. 2017;180:110–116.
  • Nicholson L, Vazquez-Alfageme C, Clemo M, et al. Quantifying retinal area in ultra-widefield imaging using a 3-dimensional printed eye model. Ophthalmol Retin. 2017. doi: https://doi.org/10.1016/j.oret.2017.03.011.
  • Franco-Cardenas V, Shah SU, Apap D, et al. Assessment of ischemic index in retinal vascular diseases using ultra-wide-field fluorescein angiography: single versus summarized image. Semin Ophthalmol. 2017;32:353–357.
  • Ehlers JP, Wang K, Vasanji A, et al. Automated quantitative characterisation of retinal vascular leakage and microaneurysms in ultra-widefield fluorescein angiography. Br J Ophthalmol. 2017. bjophthalmol-2016-310047.
  • Am L, Rusu I, Orlin A, et al. Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections. Clin Ophthalmol. 2017;11:193–200.
  • Querques L, Parravano M, Sacconi R, et al. Ischemic index changes in diabetic retinopathy after intravitreal dexamethasone implant using ultra-widefield fluorescein angiography: a pilot study. Acta Diabetol. 2017;54:769–773.
  • Campochiaro PA, Wykoff CC, Shapiro H, et al. Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema. Ophthalmology. 2014;121:1783–1789.
  • Kim DY, Kim JG, Kim YJ, et al. Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy. Investig Ophthalmol Vis Sci. 2014;55:7040–7046.
  • Rabiolo A, Parravano M, Querques L, et al. Ultra-wide-field fluorescein angiography in diabetic retinopathy: a narrative review. Clin Ophthalmol. 2017;11:803–807.
  • Muqit MMK, Marcellino GR, Henson DB, et al. Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy. Acta Ophthalmol. 2013;91:251–258.
  • Muqit MMK, Young LB, McKenzie R, et al. Pilot randomised clinical trial of pascal TargETEd retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study. Br J Ophthalmol. 2013;97:220–227.
  • Sivaprasad S, Prevost AT, Vasconcelos JC, et al. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, n. Lancet. 2017;389:2193–2203.
  • Guduru A, Martz TG, Waters A, et al. Oxygen saturation of retinal vessels in all stages of diabetic retinopathy and correlation to ultra-wide field fluorescein angiography. Investig Ophthalmol Vis Sci. 2016;57:5278–5284.
  • Leicht SF, Kernt M, Neubauer A, et al. Microaneurysm turnover in diabetic retinopathy assessed by automated RetmarkerDR image analysis - potential role as biomarker of response to ranibizumab treatment. Ophthalmologica. 2014;231:198–203.
  • Te DC, Salz DA, Waheed NK, et al. Visualization of the retinal vasculature using wide-field montage optical coherence tomography angiography. Ophthalmic Surgery, Lasers Imaging Retin. 2015;46:611–616.
  • Stanga PE, Papayannis A, Tsamis E, et al. New findings in diabetic maculopathy and proliferative disease by swept-source optical coherence tomography angiography. Dev Ophthalmol. 2016;56:113–121.
  • Rabiolo A, Cicinelli MV, Corbelli E, et al. Correlation analysis between foveal avascular zone and peripheral ischemic index in diabetic retinopathy: a pilot study. Ophthalmol Retin. 2017;100:235–239.
  • Silva PS, Cavallerano JD, Tolls D, et al. Potential efficiency benefits of nonmydriatic ultrawide field retinal imaging in an ocular telehealth diabetic retinopathy program. Diabetes Care. 2014;37:50–55.
  • Brown DM. Advancing the detection and management of diabetic retinopathy with ultra-widefield retinal imaging. 2017. p. 23–26. doi: https://doi.org/10.17925/USOR.2017.10.01.23
  • Tornambe PE. The impact of ultra-widefield retinal imaging on practice efficiency. US Ophthalmic Rev. 2017;10:27–30.
  • Sun JK, Aiello LP. The future of ultrawide field imaging for diabetic retinopathy. JAMA Ophthalmol. 2016;134:247.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.